论文部分内容阅读
目的：探讨快速PSA定性检测诊断前列腺癌的临床价值。方法：运用快速前列腺特异性抗原诊断试剂（一步法）和酶标免疫定量（Tandem-E法）对38例有尿路梗阻症状的BPH病人进行检测，结合病理学诊断对检测结果进行对比分析。结果：快速PSA诊断试剂对前列腺癌诊断有3例假阳性和1例假阴性（以PSA＞＋为标准），Tandem-E法有2例假阳性和1例假用性（以PSA＞4ng／ml为标准），两者符合率为94.74％。结论：快速PSA定性检测可作为前列腺癌筛选诊断快速有效的检测方法.可明显缩短前列腺癌的诊断时间。
Objective: To investigate the clinical value of rapid PSA qualitative diagnosis of prostate cancer. Methods: Thirty-eight BPH patients with symptoms of urinary tract obstruction were detected by rapid prostate specific antigen diagnostic reagent (one-step method) and Tandem-E method. The pathological results were compared with pathological diagnosis. Results: There were 3 false positives and 1 false negative (PSA> +) in the diagnosis of prostate cancer by the rapid PSA diagnostic reagent, 2 false positives and 1 false use in the Tandem-E method (PSA> 4 ng / ml) , The coincidence rate of both is 94.74%. Conclusion: The rapid PSA qualitative test can be used as a rapid and effective method for the screening of prostate cancer, which can significantly shorten the diagnosis time of prostate cancer.